NCT00488397View on ClinicalTrials.gov

Tigecycline In-Vitro Surveillance Study In Taiwan

CompletedOBSERVATIONAL
Enrollment

7,902

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Community Acquired Infections
Interventions
OTHER

In-vitro testing

This is an in-vitro study thus only one group in the study and there is no intervention treatment nor procedure involved in this study.

Trial Locations (1)

100

Pfizer Investigational Site, Taipei

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00488397 - Tigecycline In-Vitro Surveillance Study In Taiwan | Biotech Hunter | Biotech Hunter